Posts Tagged ‘pharmaceutical industry’

RSS

April 2nd, 2015

Liberal Changes to rt-PA Contraindications for Acute Ischemic Stroke

Dr. Craig Cocchio discussing changes to the contraindications for acute ischemic stroke, about which the FDA has been curiously silent.


August 28th, 2014

Predicting PARADIGM-HF, or What to Expect When You’re Expecting

Larry Husten analyzes the expectations surrounding the upcoming release of PARADIGM-HF and its centerpiece LCZ696 from the perspective of the medical field as well as the world of economics.


May 9th, 2013

Journal X: Not so Subtle Marketing Messages

My 3-year-old daughter helps me see the influence of pharma on research.


March 6th, 2013

The Influence of Medical School Gift Restrictions on Doctors’ Prescription Decisions

and

A new study found that gift restrictions in medical schools resulted in graduates writing fewer prescriptions of newly marketed psychiatric medications compared with older, less expensive alternatives. Might this also translate to cardiovascular agents?


February 5th, 2013

The Sun Is About to Shine

Will the Physician Payment Sunshine Act help to prevent conflict of interest or will it limit good science?


August 13th, 2012

Selections from Richard Lehman’s Literature Review: August 13th

This week’s topics include using existing data for new research; normal weight, diabetes, and non-CVD death; cholesterol levels in U.S. kids; statins and diabetes; HDL-C and MI protection; statin treatment; hypertension treatment; clopidogrel and PPIs; and an analysis behind the “innovation crisis” of the pharmaceutical industry.